Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3593]

AACR 2018: For aggressive breast cancer in the brain, researchers clarify immune response

AACR 2018: For aggressive breast cancer in the brain, researchers clarify immune response

AACR 2018: Dual inhibition of IDO1 and PD-L1 safe in patients with advanced solid tumours

AACR 2018: Dual inhibition of IDO1 and PD-L1 safe in patients with advanced solid tumours

AACR 2018: Updated data for durvalumab plus tremelimumab for NSNSCLC

AACR 2018: Updated data for durvalumab plus tremelimumab for NSNSCLC

FDA approves nivolumab plus ipilimumab combination for intermediate or poor-risk advanced renal cell carcinoma

FDA approves nivolumab plus ipilimumab combination for intermediate or poor-risk advanced renal cell carcinoma

Man-made antibodies show promise in attacking cancer cells in animal models

Man-made antibodies show promise in attacking cancer cells in animal models

Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer

AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer

AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC

AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC

AACR 2018: Combination therapy doubles survival in metastatic lung cancer

AACR 2018: Combination therapy doubles survival in metastatic lung cancer

AACR 2018: Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation

AACR 2018: Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation

More from ecancer